Status:
COMPLETED
Direct Comparison of TG and WFO LASIK
Lead Sponsor:
Taipei Nobel Eye Clinic
Conditions:
Keratomileusis, Laser In Situ
Contrast Sensitivity
Eligibility:
All Genders
20-50 years
Phase:
NA
Brief Summary
To compare the efficacy to different profiles, direct head-to-head studies had been conducted. In one previous review study revealed that TG LASIK provided patient with better uncorrected visual acuit...
Eligibility Criteria
Inclusion
- age between 20 and 50 years old
- CDVA of both eyes could reach 0.1 logarithm of the minimum angle of resolution (logMAR)
- stable refractive errors of myopia and astigmatism
Exclusion
- cataract
- corneal opacities or irregularities
- dry eye (Schirmer's test I ≤ 5mm)
- amblyopia
- coexisting ocular pathologies
- glaucoma
- non-dilating pupil
- history of intraocular surgery, laser therapy, or retinopathy
- optic nerve or macular diseases
- estimated postoperative cornea residual stromal thickness less than 250 μm
- pregnancy or under lactation
- uncontrolled diabetic mellitus or systemic immune disease
- refusal or unable to maintain follow-up
Key Trial Info
Start Date :
September 26 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT04919291
Start Date
September 26 2019
End Date
June 30 2020
Last Update
June 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Nobel Eye Clinic
Taipei, Taiwan